Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer
Explore this paper's citation graph
Summary
The above results will facilitate clinical management and prompt intervention of life-threatening electrolyte imbalance in the course of cancer treatment and help explain the physiological mechanism of carboplatin-induced electrolyte abnormality.
- Type
- article
- Published
- 2016-10-21
- Cited by
- 19
- References
- 33
- Access
- Open access
- OpenAlex
- https://openalex.org/W2538373463
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:15568614
Keywords
Carboplatin, Medicine, Adverse effect, Hyponatremia, Odds ratio
References
- Vancomycin-Resistant Staphylococcus aureus
- Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
- Drug-induced hyponatremia: an updated review.
- Drug-Induced Electrolyte Disorders
- Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
- Hypokalemia and sudden cardiac death.
- Exploring Off-Targets and Off-Systems for Adverse Drug Reactions via Chemical-Protein Interactome — Clozapine-Induced Agranulocytosis as a Case Study
- Carboplatin in the Treatment of Small Cell Lung Cancer.
- Regional brain responses associated with drinking water during thirst and after its satiation
- Carboplatin-based chemotherapy for bladder cancer.
- Symptomatic hyponatremia after voluntary excessive water ingestion in a patient without psychiatric problems.
- NEUROLOGICAL MANIFESTATIONS AND MORBIDITY OF HYPONATREMIA: CORRELATION WITH BRAIN WATER AND ELECTROLYTES
- Drug-induced Electrolyte Abnormalities
- Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit
- Cesium-associated hypokalemia successfully treated with amiloride
- FDA Adverse Event Reports on Statin-Associated Rhabdomyolysis
- Thirst and hydration status in everyday life.
- Tumor-Related Hyponatremia
- Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.
- Quantifying heterogeneity in a meta‐analysis
Cited by
- High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1
- Managing hyponatremia in lung cancer: latest evidence and clinical implications
- Upregulation of microRNA-32 is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
- Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
- miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1.
- Electrolyte disorders in cancer patients: a systematic review
- Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: A systematic review and meta-analysis.
- Electrolyte Disorders Induced by Antineoplastic Drugs
- CNOT4 suppresses non-small cell lung cancer progression and is required for effector cytolytic T lymphocytes cell responses to lung cancer cells.
- Drugs associated with drug-induced hyponatremia
- Drug-induced hyponatremia
- Revisión actualizada de la quimioterapia intraarterial para el retinoblastoma
- Pre-treatment of hyponatremia as a biomarker for poor immune prognosis in advanced or metastatic gastric cancer: A retrospective case analysis
- Revolutionizing Cancer Treatment: ROS-Induced Apoptosis via Nanoformulated Alkaloids
- An updated review of intra-arterial chemotherapy for retinoblastoma.
- Postmarketing safety evaluation of pemetrexed using FAERS and JADER databases
- Investigation of Adverse Response Expressions to Immune Checkpoint Inhibitor Therapy in PD1-Expressing Non-Small Cell Lung Cancer Patients
- The Prognostic Value of Pretreatment A Composite Biomarker of Natrium and Myeloid to Lymphoid lineage ratio in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy
- Chemotherapy Toxicities
- The Prognostic Value of Pretreatment A Composite Biomarker of Natrium and Myeloid to Lymphoid lineage ratio in Patients With Advanced or Metastatic Gastric Cancer Treated With Immunotherapy
Related papers
- Hypokalemia Clinical Diagnosis and Treatment of 52 Cases
- Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.
- Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy
- Hypokalemia in hospitalized patients in tertiary care teaching hospital Belagavi, Karnataka, India: a retrospective study
- Hypokalemia.
- Treatment of Wilms tumor using carboplatin compared to therapy without carboplatin
- Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
- Osmotic demyelination syndrome following slow correction of hyponatremia: Possible role of hypokalemia